Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Reliance Global Group, Inc. - SIC # 6400 -
Ticker
Exchange
SIC #
Website
Latest Ticker
EZRA
Nasdaq
6400
relianceglobalgroup.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Reliance Global Group, Inc.
Reliance Global Group Schedules Second Quarter 2026 Financial Results and Business Update Conference Call
- Jul 28th, 2026 6:30 am
Reliance Global Group Launches AI Agent for Secure Browser Automation in Regulated Insurance Back Offices
- Jul 14th, 2026 6:30 am
Reliance Global Group Names CTO From Coinbase and Capital One To Lead AI-Powered Insurance Product Development and Agency Roll-Up Strategy
- Jun 22nd, 2026 9:00 am
Reliance Global Group Regains Compliance with Nasdaq Continued Listing Requirements
- Jun 3rd, 2026 6:30 am
Reliance Global Group Positions ENQUANTUM to Help Secure the Post-Quantum Economy Before “Q-Day”
- Jun 1st, 2026 7:18 am
Reliance Global Group Provides Update on Enquantum Private 5G Deployment and Smart Infrastructure Initiatives
- May 18th, 2026 7:27 am
Reliance Global Group Announces Reverse Stock Split
- May 14th, 2026 4:00 am
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments
- May 7th, 2026 2:08 pm
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call
- May 6th, 2026 9:00 am
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
- May 5th, 2026 7:25 am
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division
- May 4th, 2026 6:17 am
Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones
- Apr 28th, 2026 7:17 am
Reliance Global Group to Participate in Centri Capital Conference at Nasdaq MarketSite in New York City on April 14, 2026
- Apr 10th, 2026 6:30 am
Reliance Global Group Launches RELI Exchange 2.0 to Drive Faster, More Efficient Growth
- Mar 25th, 2026 6:50 am
Reliance Global Group Funds Next Enquantum Milestone, Increasing Ownership and Securing Additional Board Seat
- Mar 19th, 2026 6:30 am
Reliance Global Group Inc (EZRA) Q4 2025 Earnings Call Highlights: Strategic Growth and ...
- Mar 10th, 2026 9:01 pm
Reliance Global Group Reports 2025 Results and Provides Strategic Update on Scale51 Initiative and Launch of EZRA International Group
- Mar 10th, 2026 2:05 pm
Reliance Global Group Schedules Fourth Quarter 2025 Financial Results and Business Update Conference Call
- Mar 6th, 2026 6:30 am
BC-Most Active Stocks
- Feb 24th, 2026 8:30 am
Reliance Global Group Closes Enquantum Transaction, Launching Path to Majority Control of Post-Quantum Cybersecurity Platform
- Feb 23rd, 2026 5:18 am
Scroll